NASDAQ : OPRX

OptimizeRx Corporation — Financial statements

Healthcare · Health Information Services · United States

Last price 9.37 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 176.49M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

OptimizeRx Corporation (OPRX) reported revenue of 98.65M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue98.65M109.43M92.13M71.52M62.45M61.29M
Cost of Revenue26.42M35.83M32.75M28.62M23.48M25.65M
Gross Profit72.24M73.59M59.38M42.90M38.97M35.64M
Selling, General & Admin48.40M50.24M49.56M40.03M33.49M27.70M
Operating Expenses60.97M61.53M65.35M56.15M51.26M35.28M
Operating Income11.26M12.06M-5.97M-13.25M-12.29M361.10K
Interest Expense-4.68M-5.29M-6.16M-1.45M
Interest & Investment Income334.00K353.00K329.00K2.19M852.30K16.98K
Other Non Operating Income (Expenses)198.00K198.00K152.00K500.00K
EBT Excluding Unusual Items7.12M7.32M-11.65M-12.01M-11.44M378.08K
Merger & Restructuring Charges-243.00K-4.27M
Impairment of Goodwill-7.49M
Gain (Loss) on Sale of Assets-2.14M
Asset Writedown-368.00K-368.00K-6.74M
Pretax Income6.75M6.95M-19.39M-25.16M-11.44M378.08K
Income Tax Expense2.15M1.82M725.00K-7.60M
Net Income4.60M5.13M-20.11M-17.57M-11.44M378.08K
Net Income to Common4.60M5.13M-20.11M-17.57M-11.44M378.08K
Shares Outstanding (Basic)18.70M18.56M18.29M17.12M17.78M17.23M
Shares Outstanding (Diluted)19.14M19.00M18.29M17.12M17.78M17.69M
EPS (Basic)0.250.28-1.10-1.03-0.640.02
EPS (Diluted)0.250.27-1.10-1.03-0.640.02
Free Cash Flow18.36M18.66M4.78M-7.33M10.57M625.72K
Free Cash Flow Per Share0.960.980.26-0.430.590.04
Gross Margin73.22%67.25%64.45%59.98%62.40%58.14%
Operating Margin11.42%11.02%-6.49%-18.53%-19.68%0.59%
Profit Margin4.66%4.69%-21.83%-24.56%-18.32%0.62%
Free Cash Flow Margin18.61%17.05%5.18%-10.24%16.93%1.02%
EBITDA15.55M16.39M-1.65M-10.85M-10.27M2.33M
EBITDA Margin15.76%14.98%-1.79%-15.17%-16.44%3.80%
D&A For EBITDA4.29M4.33M4.33M2.40M2.02M1.97M
EBIT11.26M12.06M-5.97M-13.25M-12.29M361.10K
EBIT Margin11.42%11.02%-6.48%-18.53%-19.68%0.59%
Effective Tax Rate31.85%26.16%
Advertising Expenses454.00K1.05M776.00K

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents24.10M23.36M13.38M13.85M18.21M84.68M
Short-Term Investments55.93M
Cash & Short-Term Investments24.10M23.36M13.38M13.85M74.14M84.68M
Accounts Receivable24.80M37.75M38.21M36.25M22.16M24.80M
Other Receivables2.33M752.00K1.04M
Receivables27.12M38.50M38.21M37.29M22.16M24.80M
Prepaid Expenses2.93M1.21M769.00K1.29M847.76K932.94K
Other Current Assets1.64M1.61M1.90M1.43M4.70M
Total Current Assets54.15M64.72M53.97M54.33M98.58M115.11M
Property, Plant & Equipment574.00K510.00K516.00K722.00K372.77K472.64K
Goodwill70.87M70.87M70.87M78.36M22.67M14.74M
Other Intangible Assets38.71M40.80M45.52M49.40M13.02M10.65M
Other Long-Term Assets18.00K28.00K296.00K568.00K5.05K12.86K
Total Assets164.32M176.92M171.17M183.37M134.65M140.99M
Accounts Payable1.32M1.64M2.16M2.23M1.55M606.81K
Accrued Expenses5.39M11.59M8.49M7.71M2.60M2.90M
Current Portion of Long-Term Debt1.25M4.25M2.00M2.00M
Current Portion of Leases227.00K193.00K168.00K222.00K89.90K90.98K
Current Income Taxes Payable318.00K49.00K
Current Unearned Revenue709.00K503.00K473.00K172.00K164.31K1.39M
Other Current Liabilities813.00K3.09M5.05M5.51M3.99M4.38M
Total Current Liabilities9.71M21.26M18.65M17.88M8.40M9.37M
Long-Term Debt17.76M21.42M30.82M34.23M
Long-Term Leases246.00K234.00K209.00K371.00K144.53K236.73K
Long-Term Deferred Tax Liabilities5.52M5.71M4.49M4.34M
Total Liabilities33.23M48.62M54.17M56.82M8.54M9.61M
Common Stock21.00K20.00K20.00K20.00K18.29K17.86K
Additional Paid-In Capital211.49M207.51M201.35M190.79M172.79M166.62M
Retained Earnings-80.43M-79.24M-84.37M-64.26M-46.69M-35.25M
Treasury Stock-2.00K-2.00K-2.00K-2.00K-1.21K
Comprehensive Income & Other11.00K
Shareholders' Equity131.08M128.29M117.00M126.55M126.11M131.38M
Total Liabilities & Equity164.32M176.92M171.17M183.37M134.65M140.99M
Total Debt19.48M26.10M33.19M36.82M234.43K327.71K
Net Cash (Debt)4.62M-2.74M-19.81M-22.97M73.91M84.35M
Net Cash Per Share0.24-0.14-1.08-1.344.164.77
Filing Date Shares Outstanding18.84M18.76M18.49M18.18M17.10M17.88M
Total Common Shares Outstanding18.83M18.76M18.45M18.16M17.07M17.86M
Working Capital44.44M43.45M35.32M36.45M90.18M105.74M
Book Value Per Share6.966.846.346.977.397.36
Tangible Book Value21.50M16.63M613.00K-1.20M90.41M105.99M
Tangible Book Value Per Share1.140.890.03-0.075.305.93
Machinery457.00K408.00K300.00K268.97K468.17K

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income4.60M5.13M-20.11M-17.57M-11.44M378.08K
Depreciation & Amortization4.29M4.33M4.33M2.50M2.02M2.09M
Other Amortization1.13M1.11M835.00K211.00K
Loss (Gain) From Sale of Assets2.14M
Asset Writedown & Restructuring Costs368.00K368.00K7.49M6.74M
Stock-Based Compensation7.95M6.96M11.47M13.72M15.75M5.49M
Provision & Write-off of Bad Debts208.00K666.00K363.51K80.00K
Other Operating Activities-95.00K-121.13K
Change in Accounts Receivable8.72M460.00K-2.17M-8.71M2.28M-6.99M
Change in Accounts Payable-659.00K-520.00K-72.00K-1.32M943.17K-11.44K
Change in Unearned Revenue225.00K30.00K301.00K-67.00K-1.23M1.10M
Change in Income Taxes-1.68M-1.07M
Change in Other Net Operating Assets-8.57M702.00K1.16M2.25M1.96M-1.29M
Operating Cash Flow18.43M18.71M4.89M-7.24M10.65M726.04K
Capital Expenditures-77.00K-58.00K-112.00K-87.00K-81.00K-100.32K
Sale of Property, Plant & Equipment10.00K
Cash Acquisitions-82.95M-2.00M
Divestitures2.54M
Sale (Purchase) of Intangibles217.00K126.00K-338.00K-784.00K-163.56K-385.68K
Investment in Securities55.93M-55.93M
Investing Cash Flow140.00K68.00K-450.00K-25.34M-58.18M-486.00K
Long-Term Debt Issued37.73M
Long-Term Debt Repaid-8.00M-4.00M-1.71M
Net Debt Issued (Repaid)-10.30M-8.00M-4.00M36.02M
Issuance of Common Stock352.00K352.00K1.07M80.29M
Repurchase of Common Stock-1.12M-1.15M-911.00K-7.80M-20.02M
Other Financing Activities-6.36M
Financing Cash Flow-11.07M-8.80M-4.91M28.22M-18.95M73.92M
Net Cash Flow7.51M9.98M-472.00K-4.36M-66.47M74.16M
Free Cash Flow18.36M18.66M4.78M-7.33M10.57M625.72K
Free Cash Flow Margin18.61%17.05%5.18%-10.24%16.93%1.02%
Free Cash Flow Per Share0.960.980.26-0.430.590.04
Levered Free Cash Flow15.76M16.27M9.31M-2.32M14.86M-1.40M
Unlevered Free Cash Flow17.55M18.47M12.33M-1.63M14.86M-1.40M
Cash Interest Paid2.34M4.18M6.20M1.21M
Cash Income Tax Paid1.90M1.76M161.00K48.00K
Change in Working Capital92.00K816.00K671.00K-15.55M3.96M-7.19M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization181.20M228.53M89.53M259.76M288.17M1.10B
Enterprise Value176.59M237.62M109.11M196.37M209.62M1.02B
Last Close Price9.3212.264.8614.3116.8062.11
PE Ratio39.0944.532,919.14
Forward PE10.1217.3618.0747.1839.84106.12
PS Ratio1.832.090.973.634.6118.01
PB Ratio1.341.780.772.052.298.40
P/TBV Ratio8.3913.74146.043.1910.41
P/FCF Ratio9.8312.2518.7427.251,763.84
P/OCF Ratio9.7912.2118.3127.051,520.12
PEG Ratio2.942.942.942.662.12
EV/Sales Ratio1.782.171.182.753.3616.62
EV/EBITDA Ratio11.3114.50438.00
EV/EBIT Ratio15.6119.702,821.85
EV/FCF Ratio9.5812.7422.8419.831,628.49
Debt / Equity Ratio0.150.200.280.290.000.00
Debt / EBITDA Ratio1.231.570.13
Debt / FCF Ratio1.061.406.950.020.52
Net Debt / Equity Ratio-0.040.020.170.18-0.59-0.64
Net Debt / EBITDA Ratio-0.300.17-12.04-2.127.20-36.26
Net Debt / FCF Ratio-0.250.154.15-3.13-6.99-134.81
Asset Turnover0.590.630.520.450.450.61
Quick Ratio5.272.912.772.8611.4711.69
Current Ratio5.583.042.893.0411.7412.29
Return on Equity (ROE)3.67%4.18%-16.51%-13.91%-8.88%0.42%
Return on Assets (ROA)4.22%4.33%-2.11%-5.21%-5.57%0.22%
Return on Invested Capital (ROIC)5.91%6.65%-4.17%-13.14%-24.77%0.83%
Return on Capital Employed (ROCE)7.30%7.70%-3.90%-8.00%-9.70%0.30%
Earnings Yield2.56%2.25%-22.46%-6.76%-3.97%0.03%
FCF Yield10.17%8.16%5.34%-2.82%3.67%0.06%
Buyback Yield / Dilution-3.84%-3.86%-6.82%3.71%-0.53%-19.30%